{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:17:06Z","timestamp":1785842226044,"version":"3.56.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.ygyno.2014.10.003","type":"journal-article","created":{"date-parts":[[2014,10,12]],"date-time":"2014-10-12T21:19:48Z","timestamp":1413148788000},"page":"435-440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Prognostic value of lymph node ratio in patients with advanced epithelial ovarian cancer"],"prefix":"10.1016","volume":"135","clinical-trial-number":[{"clinical-trial-number":"nct00712218","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Beyhan","family":"Ataseven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Grimm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Harter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Prader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Traut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Heitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"du Bois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2014.10.003_bb0005","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/jnci\/djs491","article-title":"Annual Report to the Nation on the Status of Cancer, 1975\u20132009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and HPV vaccination coverage levels","volume":"105","author":"Jemal","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2014.10.003_bb0010","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.24149","volume":"115","author":"du Bois","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2014.10.003_bb0015","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ygyno.2011.02.014","article-title":"Impact of a structured quality management program on surgical outcome in primary advanced ovarian cancer","volume":"121","author":"Harter","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.10.003_bb0020","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1200\/JCO.2009.25.3617","article-title":"Potential role of lymphadenectomy in advanced ovarian cancer: a combined exploratory analysis of three prospectively randomized phase III multicenter trials","volume":"28","author":"du Bois","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2014.10.003_bb0025","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/jnci\/djq149","article-title":"Surgical staging and treatment of early ovarian cancer: long-term analysis from a randomized trial","volume":"102","author":"Trimbos","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2014.10.003_bb0030","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/IGC.0b013e31821ce75d","article-title":"First-line therapy in ovarian cancer trials","volume":"21","author":"Thigpen","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2014.10.003_bb0035","doi-asserted-by":"crossref","first-page":"e43925","DOI":"10.1371\/journal.pone.0043925","article-title":"Ratio between negative and positive lymph nodes is suitable for evaluation the prognosis of gastric cancer patients with positive node metastasis","volume":"7","author":"Deng","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ygyno.2014.10.003_bb0040","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1245\/s10434-013-2932-7","article-title":"The prognostic value of lymph node ratio in node-positive breast cancer: a Dutch nationwide population-based study","volume":"20","author":"Dings","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ygyno.2014.10.003_bb0045","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1245\/s10434-012-2794-4","article-title":"The positive lymph node ratio predicts long-term survival in patients with operable thoracic esophageal squamous cell carcinoma in China","volume":"20","author":"Hou","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ygyno.2014.10.003_bb0050","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1002\/cncr.24290","article-title":"Lymph node ratio predicts disease-specific survival in melanoma patients","volume":"115","author":"Xing","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2014.10.003_bb0055","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.athoracsur.2013.04.031","article-title":"Lymph node ratio predicts recurrence and survival after R0 resection for non-small cell lung cancer","volume":"96","author":"Taylor","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ygyno.2014.10.003_bb0060","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/jso.21869","article-title":"The prognostic impact of the ratio of positive lymph nodes on survival of epithelial ovarian cancer patients","volume":"103","author":"Mahdi","year":"2011","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ygyno.2014.10.003_bb0065","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/biomet\/77.1.147","article-title":"Martingale-based residuals for survival models","volume":"77","author":"Therneau","year":"1990","journal-title":"Biometrika"},{"key":"10.1016\/j.ygyno.2014.10.003_bb0070","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ygyno.2007.05.032","article-title":"A new frontier for quality of care in gynecologic oncology surgery: multi-institutional assessment of short-term outcomes for ovarian cancer using a risk-adjusted model","volume":"107","author":"Aletti","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.10.003_bb0075","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/jnci\/dji102","article-title":"Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial","volume":"97","author":"Panici","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2014.10.003_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","article-title":"Staging classification for cancer of the ovary, fallopian tube, and peritoneum","volume":"124","author":"Prat","year":"2014","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ygyno.2014.10.003_bb0085","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ejso.2012.12.006","article-title":"Defining the optimal lymphadenectomy cut-off value in epithelial ovarian cancer staging surgery utilizing a mathematical model of validation","volume":"39","author":"Pereira","year":"2013","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2014.10.003_bb0090","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.amjsurg.2013.07.022","article-title":"Metastatic lymph node ratio in stage III rectal carcinoma is a valuable prognostic factor even with less than 12 lymph nodes retrieved: a prospective study","volume":"207","author":"Madbouly","year":"2014","journal-title":"American journal of surgery"},{"key":"10.1016\/j.ygyno.2014.10.003_bb0095","doi-asserted-by":"crossref","first-page":"168","DOI":"10.4174\/jkss.2013.84.3.168","article-title":"Impact of lymph node ratio as a valuable prognostic factor in gallbladder carcinoma, focusing on stage IIIB gallbladder carcinoma","volume":"84","author":"Choi","year":"2013","journal-title":"J Korean Surg Soc"},{"key":"10.1016\/j.ygyno.2014.10.003_bb0100","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1530\/EJE-12-0744","article-title":"The prognostic value of the metastatic lymph node ratio and maximal metastatic tumor size in pathological N1a papillary thyroid carcinoma","volume":"168","author":"Jeon","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ygyno.2014.10.003_bb0105","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1245\/s10434-013-3258-1","article-title":"Lymph node ratio of the central compartment is a significant predictor for locoregional recurrence after prophylactic central neck dissection in patients with thyroid papillary carcinoma","volume":"21","author":"Ryu","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ygyno.2014.10.003_bb0110","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ygyno.2008.09.036","article-title":"Variations in institutional infrastructure, physician specialization and experience, and outcome in ovarian cancer: a systematic review","volume":"112","author":"du Bois","year":"2009","journal-title":"Gynecol Oncol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814013523?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814013523?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T15:55:30Z","timestamp":1538150130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825814013523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0090825814013523"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2014.10.003","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic value of lymph node ratio in patients with advanced epithelial ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2014.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}